Genome-wide association and Mendelian randomization study of NT-proBNP in patients with acute coronary syndrome

Human Molecular Genetics

Volumn 25, Issue 7, 2016, Pages 1447-1456

  Johansson, Asa ^a,b   Eriksson, Niclas ^a   Lindholm, Daniel ^a,b   Varenhorst, Christoph ^a,b   James, Stefan ^a,b   Syvänen, Ann Christine ^b   Axelsson, Tomas ^b   Siegbahn, Agneta ^a,b   Barratt, Bryan ^c   Becker, Richard ^d   Himmelmann, Anders ^e   Katus, Hugo ^f   Steg, Philippe Gabriel ^g,h,i,j   Storey, Robert ^k   Wallentin, Lars ^a,b  

^a UPPSALA CLINICAL RESEARCH CENTER   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c ASTRAZENECA   (United Kingdom)

^d UNIVERSITY OF CINCINNATI ACADEMIC HEALTH CENTER   (United States)

^e ASTRAZENECA R AND D   (Sweden)

^f UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^g INSERM   (France)

^h BICHAT HOSPITAL   (France)

ⁱ UNIVERSITÉ PARIS DESCARTES   (France)

^j ROYAL BROMPTON HOSPITAL   (United Kingdom)

^k UNIVERSITY OF SHEFFIELD   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN; BRAIN NATRIURETIC PEPTIDE; CATION TRANSPORT PROTEIN; CELL CYCLE PROTEIN; N ACETYLGALACTOSAMINYLTRANSFERASE; PEPTIDE FRAGMENT; POC1B PROTEIN, HUMAN; POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; PRO-BRAIN NATRIURETIC PEPTIDE (1-76); ZIP8 PROTEIN, HUMAN;

ACUTE CORONARY SYNDROME; ARTICLE; CHROMOSOME 12; CHROMOSOME 4; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MENDELIAN RANDOMIZATION ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; CLINICAL TRIAL; GENETICS; GENOME-WIDE ASSOCIATION STUDY; MIDDLE AGED;

ACUTE CORONARY SYNDROME; CATION TRANSPORT PROTEINS; CELL CYCLE PROTEINS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; N-ACETYLGALACTOSAMINYLTRANSFERASES; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84963729158     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddw012     Document Type: Article

References (51)

1. Jernberg, T., James, S., Lindahl, B., Stridsberg, M., Venge, P. and Wallentin, L. (2004) NT-proBNP in unstable coronary artery disease-experiences from the FAST, GUSTO IV and FRISC II trials. Eur. J. Hear. Fail., 6, 319-325.
2. Bibbins-Domingo,K., Gupta, R.,Na, B.,Wu, A.H., Schiller, N.B. and Whooley, M.A. (2007) N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease. JAMA, 297, 169-176.
3. Wallentin, L., Lindholm, D., Siegbahn, A., Wernroth, L., Becker, R.C., Cannon, C.P., Cornel, J.H., Himmelmann, A., Giannitsis, E., Harrington, R.A. et al. (2014) Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial. Circulation, 129, 293-303.
4. Olsson, L.G., Swedberg, K., Cleland, J.G., Spark, P.A., Komajda, M., Metra, M., Torp-Pedersen, C., Remme, W.J., Scherhag, A. and Poole-Wilson, P. (2007) Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a beta-blocker: results from the Carvedilol or Metoprolol European Trial (COMET) trial. Eur. J. Hear. Fail., 9, 795-801.
5. Hijazi, Z., Oldgren, J., Andersson, U., Connolly, S.J., Ezekowitz, M.D., Hohnloser, S.H., Reilly, P.A., Vinereanu, D., Siegbahn, A., Yusuf, S. et al. (2012) Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a randomized evaluation of long-term anticoagulation therapy (RE-LY) substudy. Circulation, 125, 1605-1616.
6. Semenov, A.G. and Seferian, K.R. (2011) Biochemistry of the human B-type natriuretic peptide precursor and molecular aspects of its processing. Clin. Chim. Acta, 412, 850-860.
7. Daniels, L.B. and Maisel, A.S. (2007) Natriuretic peptides. J. Am. Coll. Cardiol., 50, 2357-2368.
8. Morita, E., Yasue, H., Yoshimura, M., Ogawa, H., Jougasaki, M., Matsumura, T., Mukoyama, M. and Nakao, K. (1993) Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation, 88, 82-91.
9. Del Greco, M.F., Pattaro, C., Luchner, A., Pichler, I.,Winkler, T., Hicks, A.A., Fuchsberger, C., Franke, A., Melville, S.A., Peters, A. et al. (2011) Genome-wide association analysis and fine mapping of NT-proBNP level provide novel insight into the role of the MTHFR-CLCN6-NPPA-NPPB gene cluster. Hum. Mol. Genet., 20, 1660-1671.
10. Takeishi, Y., Toriyama, S., Takabatake, N., Shibata, Y., Konta, T., Emi, M., Kato, T., Kawata, S. and Kubota, I. (2007) Linkage disequilibrium analyses of natriuretic peptide precursor B locus reveal risk haplotype conferring high plasma BNP levels. Biochem. Biophys. Res. Commun., 362, 480-484.
11. Newton-Cheh, C., Larson, M.G., Vasan, R.S., Levy, D., Bloch K.D., Surti, A., Guiducci, C., Kathiresan, S., Benjamin, E.J., Struck, J. et al. (2009) Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure. Nat. Genet., 41, 348-353.
12. Yan, W., Wu, F., Morser, J. and Wu, Q. (2000) Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme. Proc. Natl. Acad. Sci. USA., 97, 8525-8529.
13. Semenov, A.G., Tamm, N.N., Seferian, K.R., Postnikov, A.B., Karpova, N.S., Serebryanaya, D.V., Koshkina, E.V., Krasnoselsky, M.I. and Katrukha, A.G. (2010) Processing of pro-B-type natriuretic peptide: furin and corin as candidate convertases. Clin. Chem., 56, 1166-1176.
14. Ehret, G.B., Munroe, P.B., Rice, K.M., Bochud,M., Johnson, A.D., Chasman, D.I., Smith, A.V., Tobin, M.D., Verwoert, G.C., Hwang, S.J. et al. (2011) Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature, 478, 103-109.
15. Deloukas, P., Kanoni, S., Willenborg, C., Farrall, M., Assimes, T.L., Thompson, J.R., Ingelsson, E., Saleheen, D., Erdmann, J., Goldstein, B.A. et al. (2013) Large-scale association analysis identifies newrisk loci for coronary artery disease. Nat. Genet., 45, 25-33.
16. Meirhaeghe, A., Sandhu, M.S., McCarthy, M.I., de Groote, P., Cottel, D., Arveiler, D., Ferrieres, J., Groves, C.J., Hattersley, A.T., Hitman, G.A. et al. (2007) Association between the T- 381C polymorphism of the brain natriuretic peptide gene and risk of type 2 diabetes in human populations. Hum. Mol. Genet., 16, 1343-1350.
17. Teslovich, T.M., Musunuru, K., Smith, A.V., Edmondson, A.C., Stylianou, I.M., Koseki, M., Pirruccello, J.P., Ripatti, S., Chasman, D.I.,Willer, C.J. et al. (2010) Biological, clinical and population relevance of 95 loci for blood lipids. Nature, 466, 707-713.
18. Waterworth, D.M., Ricketts, S.L., Song, K., Chen, L., Zhao, J.H., Ripatti, S., Aulchenko, Y.S., Zhang, W., Yuan, X., Lim, N. et al. (2010) Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arter. Thromb. Vasc. Biol., 30, 2264-2276.
19. Speliotes, E.K.,Willer, C.J., Berndt, S.I., Monda, K.L., Thorleifsson, G., Jackson, A.U., Lango Allen, H., Lindgren, C.M., Luan, J., Magi, R. et al. (2010) Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat. Genet., 42, 937-948.
20. Wain, L.V., Verwoert, G.C., O'Reilly, P.F., Shi, G., Johnson, T., Johnson, A.D., Bochud, M., Rice, K.M., Henneman, P., Smith, A.V. et al. (2011) Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat. Genet., 43, 1005-1011.
21. Pfister, R., Luben, R.N., Khaw, K.T. and Wareham, N.J. (2013) Common genetic variants of the natriuretic peptide gene locus are not associated with heart failure risk in participants in the EPIC-Norfolk study. Eur. J. Hear. Fail., 15, 624-627.
22. Choquet, H., Cavalcanti-Proenca, C., Lecoeur, C., Dina, C., Cauchi, S., Vaxillaire, M., Hadjadj, S., Horber, F., Potoczna, N., Charpentier, G. et al. (2009) The T-381C SNP in BNP gene may be modestly associated with type 2 diabetes: an updated meta-analysis in 49 279 subjects. Hum. Mol. Genet., 18, 2495- 2501.
23. Pfister, R., Sharp, S., Luben, R.,Welsh, P., Barroso, I., Salomaa, V., Meirhaeghe, A., Khaw, K.T., Sattar, N., Langenberg, C. et al. (2011) Mendelian randomization study of B-type natriuretic peptide and type 2 diabetes: evidence of causal association from population studies. PLoS Med., 8, e1001112.
24. Ellis, K.L., Newton-Cheh, C., Wang, T.J., Frampton, C.M., Doughty, R.N., Whalley, G.A., Ellis, C.J., Skelton, L., Davis, N., Yandle, T.G. et al. (2011) Association of genetic variation in the natriuretic peptide system with cardiovascular outcomes. J. Mol. Cell Cardiol., 50, 695-701.
25. Carrera, N., Arrojo, M., Sanjuan, J., Ramos-Rios, R., Paz, E., Suarez-Rama, J.J., Paramo, M., Agra, S., Brenlla, J., Martinez, S. et al. (2012) Association study of nonsynonymous single nucleotide polymorphisms in schizophrenia. Biol. Psychiatry, 71, 169-177.
26. Price, A.L., Helgason, A., Palsson, S., Stefansson, H., St Clair, D., Andreassen, O.A., Reich, D., Kong, A. and Stefansson, K. (2009) The impact of divergence time on the nature of population structure: an example from Iceland. PLoS Genet., 5, e1000505.
27. He, L., Girijashanker, K., Dalton, T.P., Reed, J., Li, H., Soleimani, M. and Nebert, D.W. (2006) ZIP8, member of the solutecarrier- 39 (SLC39) metal-transporter family: characterization of transporter properties. Mol. Pharmacol., 70, 171-180.
28. Liu, Z., Li, H., Soleimani, M., Girijashanker, K., Reed, J.M., He, L., Dalton, T.P. and Nebert, D.W. (2008) Cd2+ versus Zn2+ uptake by the ZIP8 HCO3-dependent symporter: kinetics, electrogenicity and trafficking. Biochem. Biophys. Res. Commun., 365, 814-820.
29. Wang, C.Y., Jenkitkasemwong, S., Duarte, S., Sparkman, B.K., Shawki, A., Mackenzie, B. and Knutson, M.D. (2012) ZIP8 is an iron and zinc transporter whose cell-surface expression is up-regulated by cellular iron loading. J. Biol. Chem., 287, 34032-34043.
30. Begum, N.A., Kobayashi, M., Moriwaki, Y., Matsumoto, M., Toyoshima, K. and Seya, T. (2002) Mycobacterium bovis BCG cell wall and lipopolysaccharide induce a novel gene, BIGM103, encoding a 7-TM protein: identification of a new protein family having Zn-transporter and Zn-metalloprotease signatures. Genomics, 80, 630-645.
31. Liu, M.J., Bao, S., Galvez-Peralta, M., Pyle, C.J., Rudawsky, A.C., Pavlovicz, R.E., Killilea, D.W., Li, C., Nebert, D.W., Wewers M.D. et al. (2013) ZIP8 regulates host defense through zincmediated inhibition of NF-kappaB. Cell Rep., 3, 386-400.
32. Bennett, E.P., Hassan, H. and Clausen, H. (1996) cDNA cloning and expression of a novel human UDP-N-acetyl-alpha-d-galactosamine. Polypeptide N-acetylgalactosaminyltransferase, GalNAc-t3. J. Biol. Chem., 271, 17006-17012.
33. O'Halloran, A.M., Patterson, C.C., Horan, P., Maree, A., Curtin, R., Stanton, A., McKeown, P.P. and Shields, D.C. (2009) Genetic polymorphisms in platelet-related proteins and coronary artery disease: investigation of candidate genes, including N-acetylgalactosaminyltransferase 4 (GALNT4) and sulphotransferase 1A1/2 (SULT1A1/2). J. Thromb. Thrombolysis, 27, 175-184.
34. Lu, X., Wang, L., Chen, S., He, L., Yang, X., Shi, Y., Cheng, J., Zhang, L., Gu, C.C., Huang, J. et al. (2012) Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease. Nat. Genet., 44, 890-894.
35. Erbilgin, A., Civelek, M., Romanoski, C.E., Pan, C., Hagopian, R., Berliner, J.A. and Lusis, A.J. (2013) Identification of CAD candidate genes in GWAS loci and their expression in vascular cells. J. Lipid Res., 54, 1894-1905.
36. Zeller, T.,Wild, P., Szymczak, S., Rotival, M., Schillert, A., Castagne, R., Maouche, S., Germain, M., Lackner, K., Rossmann, H. et al. (2010) Genetics and beyond-the transcriptome of human monocytes and disease susceptibility. PLoS One, 5, e10693.
37. Semenov, A.G., Postnikov, A.B., Tamm, N.N., Seferian, K.R., Karpova, N.S., Bloshchitsyna, M.N., Koshkina, E.V., Krasnoselsky, M.I., Serebryanaya, D.V. and Katrukha, A.G. (2009) Processing of pro-brain natriuretic peptide is suppressed by O-glycosylation in the region close to the cleavage site. Clin. Chem., 55, 489-498.
38. James, S., Akerblom, A., Cannon, C.P., Emanuelsson, H., Husted, S., Katus, H., Skene, A., Steg, P.G., Storey, R.F., Harrington, R. et al. (2009) Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial. Am. Heart J., 157, 599-605.
39. Wallentin, L., Becker, R.C., Budaj, A., Cannon, C.P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H. et al. (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med., 361, 1045-1057.
40. Gunderson, K.L., Steemers, F.J., Lee, G., Mendoza, L.G. and Chee, M.S. (2005) A genome-wide scalable SNP genotyping assay using microarray technology. Nat. Genet., 37, 549-554.
41. Steemers, F.J., Chang, W., Lee, G., Barker, D.L., Shen, R. and Gunderson, K.L. (2006) Whole-genome genotyping with the single-base extension assay. Nat. Methods, 3, 31-33.
42. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M.A., Bender, D., Maller, J., Sklar, P., de Bakker, P.I., Daly, M.J. et al. (2007) PLINK: a tool set forwhole-genomeassociation and population- based linkage analyses. Am. J. Hum. Genet., 81, 559-575.
43. Aulchenko, Y.S., Ripke, S., Isaacs, A. and van Duijn, C.M. (2007) GenABEL: an R library for genome-wide association analysis. Bioinformatics, 23, 1294-1296.
44. Howie, B., Fuchsberger, C., Stephens, M., Marchini, J. and Abecasis, G.R. (2012) Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat. Genet., 44, 955-959.
45. Delaneau, O., Zagury, J.F. and Marchini, J. (2013) Improved whole-chromosome phasing for disease and population genetic studies. Nat. Methods, 10, 5-6.
46. Howie, B.N., Donnelly, P. and Marchini, J. (2009) A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet., 5, e1000529.
47. Abecasis, G.R., Auton, A., Brooks, L.D., DePristo, M.A., Durbin, R.M., Handsaker, R.E., Kang, H.M., Marth, G.T. and McVean G.A. (2012) An integrated map of genetic variation from 1,092 human genomes. Nature, 491, 56-65.
48. Price, A.L., Patterson, N.J., Plenge, R.M., Weinblatt, M.E., Shadick, N.A. and Reich, D. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet., 38, 904-909.
49. Aulchenko, Y.S., Struchalin, M.V. and van Duijn, C.M. (2010) ProbABEL package for genome-wide association analysis of imputed data. BMC Bioinformatics, 11, 134.
50. Ng, P.C. and Henikoff, S. (2003) SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res., 31, 3812-3814.
51. Adzhubei, I.A., Schmidt, S., Peshkin, L., Ramensky, V.E., Gerasimova, A., Bork, P., Kondrashov, A.S. and Sunyaev, S.R. (2010) A method and server for predicting damaging missense mutations. Nat. Methods, 7, 248-249.